Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics and the Society forMaternal-FetalMedicin (2019) ACOG Practice Bulletin No. 204: fetal growth restriction. Obstet Gynecol 133:e97–e109
2. Burton GJ, Redman CW, Roberts JM, Moffett A (2019) Pre-eclampsia: pathophysiology and clinical implications. BMJ 366:l2381
3. Chen HL, Yang YP, Hu XL et al (1991) Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol 139:327–335
4. Baack ML, Wang C, Hu S et al (2014) Hyperglycemia induces embryopathy, even in the absence of systemic maternal diabetes: an in vivo test of the fuel mediated teratogenesis hypothesis. Reprod Toxicol 46:129–136
5. Kameda T, Matsuzaki N, Sawai K et al (1990) Production of interleukin-6 by normal human trophoblast. Placenta 11:205–213